Carcinoma in situ of right eye
ICD-10 D09.21 is a billable code used to indicate a diagnosis of carcinoma in situ of right eye.
Carcinoma in situ (CIS) of the right eye refers to a localized, non-invasive form of cancer that is confined to the epithelial layer of the eye. This condition is characterized by abnormal cell growth that has not yet invaded surrounding tissues. The right eye may be affected by various types of carcinoma in situ, including squamous cell carcinoma and basal cell carcinoma. Diagnosis typically involves a thorough examination, including imaging studies and possibly a biopsy to confirm the presence of atypical cells. Surveillance protocols for patients diagnosed with carcinoma in situ of the right eye often include regular ophthalmologic evaluations to monitor for any signs of progression or invasion. The risk of progression to invasive cancer varies based on factors such as the type of carcinoma, the patient's overall health, and the adequacy of treatment. Early detection and intervention are crucial to prevent the development of invasive cancer, making ongoing surveillance essential for affected individuals.
Detailed clinical notes including examination findings, imaging results, and treatment plans.
Routine surveillance visits, treatment planning for carcinoma in situ, and post-treatment follow-ups.
Ensure clear documentation of the type of carcinoma and any changes in the patient's condition.
Comprehensive treatment records, including chemotherapy or radiation therapy details if applicable.
Consultations for treatment options, management of side effects, and coordination of care.
Document any interdisciplinary treatment plans and patient education provided.
Used when a patient with carcinoma in situ undergoes surgical excision of the lesion.
Document the size, location, and type of lesion excised.
Ophthalmology should ensure that the excision is documented in the context of the carcinoma in situ.
Carcinoma in situ of the right eye is significant as it indicates a localized cancer that has not invaded surrounding tissues. Early detection and treatment are crucial to prevent progression to invasive cancer.
